SWOG clinical trial number
SWOG-8735
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia
Closed
Phase
Accrual
57%
Abbreviated Title
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia
Activated
04/01/1988
Closed
05/15/1990